Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Two-year downside put Buyer in Teva » 15:00
12/01/21
12/01
15:00
12/01/21
15:00
TEVA

Teva

$8.25 /

+0.005 (+0.06%)

Two-year downside put…

Two-year downside put Buyer in Teva. Initiator paid $1.39 for 5500 Jan 7 Puts at $1.39 tied to 148,500 shares at $8.35. $764k block of premium opens a new position expiring in two-years.

ShowHide Related Items >><<
TEVA Teva
$8.25 /

+0.005 (+0.06%)

TEVA Teva
$8.25 /

+0.005 (+0.06%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TEVA Teva
$8.25 /

+0.005 (+0.06%)

TEVA Teva
$8.25 /

+0.005 (+0.06%)

TEVA Teva
$8.25 /

+0.005 (+0.06%)

TEVA Teva
$8.25 /

+0.005 (+0.06%)

Hot Stocks
Teva launches authorized generic of Epiduo Forte Gel in U.S. » 08:25
12/01/21
12/01
08:25
12/01/21
08:25
TEVA

Teva

$8.25 /

-0.345 (-4.02%)

Teva Pharmaceuticals …

Teva Pharmaceuticals announced the launch of an authorized generic of Epiduo Forte Gel, adapalene and benzoyl peroxide gel 0.3%/2.5%, in the United States. Adapalene and benzoyl peroxide gel 0.3%/2.5% is a topical prescription medicine used to treat acne vulgaris. "The launch of our first-to-market authorized generic version of Epiduo Forte Gel in the U.S. provides patients with another important treatment option," said Christine Baeder, SVP, Chief Operating Officer US Generics, Teva USA. "Continuing to advance and launch much-needed generic drugs is critical to ensuring access to quality medicines to everyone who needs them." With nearly 550 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the market, and holds the leading position in first-to-file opportunities, with approximately 100 pending first-to-files in the U.S. Currently, 1 in 11 generic prescriptions dispensed in the U.S. is filled with a Teva generic product. Epiduo Forte Gel had annual sales of $253M in the U.S., according to IQVIA data, as of September .

ShowHide Related Items >><<
TEVA Teva
$8.25 /

-0.345 (-4.02%)

TEVA Teva
$8.25 /

-0.345 (-4.02%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TEVA Teva
$8.25 /

-0.345 (-4.02%)

TEVA Teva
$8.25 /

-0.345 (-4.02%)

TEVA Teva
$8.25 /

-0.345 (-4.02%)

TEVA Teva
$8.25 /

-0.345 (-4.02%)

Over a week ago
Options
Teva call volume above normal and directionally bullish » 12:05
11/24/21
11/24
12:05
11/24/21
12:05
TEVA

Teva

$8.72 /

-0.02 (-0.23%)

Bullish option flow…

Bullish option flow detected in Teva with 16,748 calls trading, 1.1x expected, and implied vol increasing over 2 points to 41.37%. Jan-22 11 calls and Jan-22 10 calls are the most active options, with total volume in those strikes near 10,000 contracts. The Put/Call Ratio is 0.16. Earnings are expected on February 2nd.

ShowHide Related Items >><<
TEVA Teva
$8.72 /

-0.02 (-0.23%)

TEVA Teva
$8.72 /

-0.02 (-0.23%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TEVA Teva
$8.72 /

-0.02 (-0.23%)

TEVA Teva
$8.72 /

-0.02 (-0.23%)

TEVA Teva
$8.72 /

-0.02 (-0.23%)

TEVA Teva
$8.72 /

-0.02 (-0.23%)

Options
Teva call volume above normal and directionally bullish » 14:25
11/10/21
11/10
14:25
11/10/21
14:25
TEVA

Teva

$9.51 /

+0.22 (+2.37%)

Bullish option flow…

Bullish option flow detected in Teva with 29,303 calls trading, 1.1x expected, and implied vol increasing over 11 points to 68.40%. Jan-23 10 calls and Jan-23 7 calls are the most active options, with total volume in those strikes near 15,900 contracts. The Put/Call Ratio is 0.06. Earnings are expected on February 2nd.

ShowHide Related Items >><<
TEVA Teva
$9.51 /

+0.22 (+2.37%)

TEVA Teva
$9.51 /

+0.22 (+2.37%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TEVA Teva
$9.51 /

+0.22 (+2.37%)

TEVA Teva
$9.51 /

+0.22 (+2.37%)

TEVA Teva
$9.51 /

+0.22 (+2.37%)

TEVA Teva
$9.51 /

+0.22 (+2.37%)

Hot Stocks
Teva reports interim results from FINESSE study » 05:13
11/08/21
11/08
05:13
11/08/21
05:13
TEVA

Teva

$9.13 /

-0.095 (-1.03%)

Teva Germany presented at…

Teva Germany presented at the DGN Congress the first interim analysis results of the FINESSE study aiming to provide real-world evidence of fremanezumab treatment outcomes by evaluating effectiveness in routine clinical practice. 97.6% of patients included in the study had already received preventive migraine therapies in the 10 years prior to study entry, including antidepressants, anticonvulsants, beta-blockers, ca-antagonists, onabotulinumtoxinA as well as other anti-CGRP mAbs. The interim analysis results were shared in a poster presentation at the congress by Professor Andreas Straube, from Ludwig-Maximilians University Munich, Germany, who is the principal investigator of the study. The presented FINESSE interim data indicate that real-world response rates are consistent with Phase-III-study results of fremanezumab. The primary endpoint measure was the proportion of patients reaching 50% reduction in the monthly average number of migraine days evaluated during the 6-month period after the first dose of fremanezumab. Overall, 48.7% of the patients with six-month data achieved the primary endpoint, with a higher percentage in EM than CM patients. Real-world response rates are thus in line with Phase-III-study results of fremanezumab. The mean number of migraine days per month decreased from 12.7 to 6.2. From baseline to month six, the mean MIDAS Score decreased from 74.8 at baseline to 32.8 and the mean HIT-6 Score from 65.9 at baseline to 56.6. Acute migraine medication use decreased from 9.6 days/month at baseline to 4.4 d/m at month six.

ShowHide Related Items >><<
TEVA Teva
$9.13 /

-0.095 (-1.03%)

TEVA Teva
$9.13 /

-0.095 (-1.03%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TEVA Teva
$9.13 /

-0.095 (-1.03%)

TEVA Teva
$9.13 /

-0.095 (-1.03%)

TEVA Teva
$9.13 /

-0.095 (-1.03%)

TEVA Teva
$9.13 /

-0.095 (-1.03%)

Over a month ago
On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:53
11/02/21
11/02
16:53
11/02/21
16:53
PFE

Pfizer

$45.48 /

+1.85 (+4.24%)

, TSLA

Tesla

$1,171.99 /

-37.38 (-3.09%)

, DD

DuPont

$77.52 /

+6.275 (+8.81%)

, HTZZ

Hertz

$35.06 /

+0.91 (+2.66%)

, ROG

Rogers Corporation

$270.56 /

+63.56 (+30.71%)

, FB

Facebook; also tag MVRS

$328.17 /

-1.83 (-0.55%)

, NFLX

Netflix

$677.50 /

-3.64 (-0.53%)

, CHGG

Chegg

$32.12 /

-30.68 (-48.85%)

, XOM

Exxon Mobil

$64.82 /

-0.8 (-1.22%)

, F

Ford

$18.02 /

+0.07 (+0.39%)

, EXPE

Expedia

$159.86 /

-7.29 (-4.36%)

, YY

Joyy

$48.42 /

-3.265 (-6.32%)

, AAPL

Apple

$150.03 /

+1.06 (+0.71%)

, NTDOY

Nintendo

$53.57 /

-1.97 (-3.55%)

, JNJ

Johnson & Johnson

$165.60 /

+2.58 (+1.58%)

, TEVA

Teva

$10.12 /

+0.89 (+9.64%)

, ENDP

Endo

$5.09 /

+0.46 (+9.94%)

, ABBV

AbbVie

$116.53 /

+1.63 (+1.42%)

, CAR

Avis Budget

$358.30 /

+186.74 (+108.85%)

, SWBK

Switchback II

$8.19 /

-1.81 (-18.10%)

, ANET

Arista Networks

$491.41 /

+82.83 (+20.27%)

, TRIT

Triterras

$5.43 /

-2.075 (-27.67%)

, GPN

Global Payments

$132.36 /

-13.315 (-9.14%)

, BP

BP

$27.96 /

-1.32 (-4.51%)

, UAA

Under Armour

$25.58 /

+3.595 (+16.36%)

, UA

Under Armour

$21.68 /

+2.655 (+13.96%)

, SPG

Simon Property

$159.00 /

+9.79 (+6.56%)

, EL

Estee Lauder

$338.62 /

+13.305 (+4.09%)

, CLX

Clorox

$165.36 /

+1.84 (+1.13%)

, MSFT

Microsoft

$333.26 /

+3.43 (+1.04%)

Get caught up quickly on…

ShowHide Related Items >><<
YY Joyy
$48.42 /

-3.265 (-6.32%)

XOM Exxon Mobil
$64.82 /

-0.8 (-1.22%)

UAA Under Armour
$25.58 /

+3.595 (+16.36%)

UA Under Armour
$21.68 /

+2.655 (+13.96%)

TSLA Tesla
$1,171.99 /

-37.38 (-3.09%)

TRIT Triterras
$5.43 /

-2.075 (-27.67%)

TEVA Teva
$10.12 /

+0.89 (+9.64%)

SWBK Switchback II
$8.19 /

-1.81 (-18.10%)

SPG Simon Property
$159.00 /

+9.79 (+6.56%)

ROG Rogers Corporation
$270.56 /

+63.56 (+30.71%)

PFE Pfizer
$45.48 /

+1.85 (+4.24%)

NTDOY Nintendo
$53.57 /

-1.97 (-3.55%)

NFLX Netflix
$677.50 /

-3.64 (-0.53%)

MSFT Microsoft
$333.26 /

+3.43 (+1.04%)

JNJ Johnson & Johnson
$165.60 /

+2.58 (+1.58%)

HTZZ Hertz
$35.06 /

+0.91 (+2.66%)

GPN Global Payments
$132.36 /

-13.315 (-9.14%)

FB Facebook; also tag MVRS
$328.17 /

-1.83 (-0.55%)

F Ford
$18.02 /

+0.07 (+0.39%)

EXPE Expedia
$159.86 /

-7.29 (-4.36%)

ENDP Endo
$5.09 /

+0.46 (+9.94%)

EL Estee Lauder
$338.62 /

+13.305 (+4.09%)

DD DuPont
$77.52 /

+6.275 (+8.81%)

CLX Clorox
$165.36 /

+1.84 (+1.13%)

CHGG Chegg
$32.12 /

-30.68 (-48.85%)

CAR Avis Budget
$358.30 /

+186.74 (+108.85%)

BP BP
$27.96 /

-1.32 (-4.51%)

ANET Arista Networks
$491.41 /

+82.83 (+20.27%)

ABBV AbbVie
$116.53 /

+1.63 (+1.42%)

AAPL Apple
$150.03 /

+1.06 (+0.71%)

PFE Pfizer
$45.48 /

+1.85 (+4.24%)

11/03/21 Craig-Hallum
Exact Sciences price target lowered to $133 from $144 at Craig-Hallum
11/03/21 Baird
Exact Sciences price target lowered to $116 from $125 at Baird
11/02/21 JPMorgan
Pfizer core sales modestly below expectations, says JPMorgan
10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
TSLA Tesla
$1,171.99 /

-37.38 (-3.09%)

11/02/21 Bernstein
Bernstein sees several structural forces helping Tesla gross margins next year
10/29/21 Canaccord
STMicroelectronics price target raised to $60 from $51 at Canaccord
10/27/21 Piper Sandler
Tesla price target raised to $1,300 from $1,200 at Piper Sandler
10/27/21 Wedbush
Other bulk deals to follow and further benefit Tesla, says Wedbush
DD DuPont
$77.52 /

+6.275 (+8.81%)

11/03/21 BMO Capital
DuPont price target raised to $101 from $96 at BMO Capital
11/03/21 Deutsche Bank
DuPont price target raised to $95 from $92 at Deutsche Bank
11/03/21 Mizuho
DuPont price target raised to $96 from $94 at Mizuho
11/03/21 Credit Suisse
DuPont upgraded to Outperform from Neutral at Credit Suisse
HTZZ Hertz
$35.06 /

+0.91 (+2.66%)

10/27/21 William Blair
Deal with Hertz could 'meaningfully' boost Carvana sales, says William Blair
10/27/21 Goldman Sachs
Goldman ups Tesla target to $1,125 after 'important' Hertz order
ROG Rogers Corporation
$270.56 /

+63.56 (+30.71%)

11/03/21 Wolfe Research
Rogers Corporation downgraded to Peer Perform from Outperform at Wolfe Research
11/02/21 B. Riley
Rogers Corporation downgraded to Neutral from Buy at B. Riley
07/30/21 Canaccord
Rogers Corporation price target lowered to $233 from $260 at Canaccord
FB Facebook; also tag MVRS
$328.17 /

-1.83 (-0.55%)

11/01/21 Citi
Citi upgrades Snap to Neutral, cuts price target to $53
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
10/27/21 Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
NFLX Netflix
$677.50 /

-3.64 (-0.53%)

10/20/21
Fly Intel: Top five analyst downgrades
10/20/21 Cowen
Netflix price target raised to $750 from $650 at Cowen
10/20/21 Wedbush
Netflix stagnating ARPU, rising costs overshadow subscriber growth, says Wedbush
10/20/21 Oppenheimer
Netflix price target raised to $750 from $620 at Oppenheimer
CHGG Chegg
$32.12 /

-30.68 (-48.85%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 BMO Capital
Chegg price target lowered to $49 from $74 at BMO Capital
11/02/21 Raymond James
Chegg downgraded to Market Perform from Outperform at Raymond James
11/02/21 Barrington
Chegg earnings selloff a buying opportunity, says Barrington
XOM Exxon Mobil
$64.82 /

-0.8 (-1.22%)

11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
F Ford
$18.02 /

+0.07 (+0.39%)

11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
11/02/21 Nomura
Ford downgraded to Reduce from Neutral at Nomura
10/29/21 Tigress Financial
Snap-On price target raised to $295 from $289 at Tigress Financial
10/28/21 Benchmark
Ford price target raised to $20 from $18 at Benchmark
EXPE Expedia
$159.86 /

-7.29 (-4.36%)

11/02/21 Atlantic Equities
Expedia downgraded to Neutral on valuation at Atlantic Equities
11/02/21 Atlantic Equities
Expedia downgraded to Neutral from Overweight at Atlantic Equities
09/13/21 Goldman Sachs
Expedia initiated with a Buy at Goldman Sachs
YY Joyy
$48.42 /

-3.265 (-6.32%)

11/02/21 Morgan Stanley
Joyy named as Research Tactical Idea at Morgan Stanley
11/01/21 Goldman Sachs
Joyy downgraded to Sell from Neutral at Goldman Sachs
08/19/21 Benchmark
Joyy price target lowered to $97 from $165 at Benchmark
07/16/21 Morgan Stanley
Joyy price target lowered to $80 from $141 at Morgan Stanley
AAPL Apple
$150.03 /

+1.06 (+0.71%)

11/02/21 Morgan Stanley
Apple 10-K highlights strong advertising growth, says Morgan Stanley
11/01/21 Canaccord
Apple results show underlying demand remains strong, says Canaccord
10/29/21 Evercore ISI
Apple still positioned for mid-teens EPS growth in FY22, says Evercore ISI
10/29/21 Citi
Apple sales miss not 'thesis changer,' says Citi
NTDOY Nintendo
$53.57 /

-1.97 (-3.55%)

10/28/21 Wedbush
Nintendo upgraded to Outperform from Neutral at Wedbush
10/01/21 DZ Bank
Nintendo downgraded to Hold from Buy at DZ Bank
08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
JNJ Johnson & Johnson
$165.60 /

+2.58 (+1.58%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
TEVA Teva
$10.12 /

+0.89 (+9.64%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
ENDP Endo
$5.09 /

+0.46 (+9.94%)

08/31/21 Piper Sandler
Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
08/31/21 Piper Sandler
Endo downgraded to Neutral from Overweight at Piper Sandler
08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
ABBV AbbVie
$116.53 /

+1.63 (+1.42%)

11/01/21 Morgan Stanley
AbbVie price target raised to $124 from $116 at Morgan Stanley
10/29/21 Piper Sandler
AbbVie price target raised to $129 from $124 at Piper Sandler
10/19/21 Morgan Stanley
Regenxbio assumed with an Overweight at Morgan Stanley
10/05/21 Piper Sandler
Biohaven Pharmaceutical price target raised to $156 from $140 at Piper Sandler
CAR Avis Budget
$358.30 /

+186.74 (+108.85%)

11/03/21 Deutsche Bank
Deutsche can't justify Avis Budget rally, downgrades shares to Sell
11/03/21 JPMorgan
JPMorgan double downgrades Avis Budget to sell after 'short squeeze'
11/03/21 JPMorgan
Avis Budget downgraded to Underweight from Overweight at JPMorgan
11/03/21 Deutsche Bank
Avis Budget downgraded to Sell from Hold at Deutsche Bank
SWBK Switchback II
$8.19 /

-1.81 (-18.10%)

09/23/21 DA Davidson
Switchback II initiated with a Buy at DA Davidson
08/30/21 Capital One
Switchback II initiated with an Overweight at Capital One
ANET Arista Networks
$491.41 /

+82.83 (+20.27%)

11/02/21 BofA
Arista Networks price target raised to $480 from $400 at BofA
11/02/21 Cowen
Arista Networks price target raised to $535 from $433 at Cowen
11/02/21 Evercore ISI
Arista Networks price target raised to $520 from $480 at Evercore ISI
11/02/21 Morgan Stanley
Arista Networks price target raised to $460 from $420 at Morgan Stanley
TRIT Triterras
$5.43 /

-2.075 (-27.67%)

11/02/21 B. Riley
Triterras downgraded to Neutral from Buy at B. Riley
05/18/21 B. Riley
Triterras price target lowered to $9 from $12 at B. Riley
02/01/21 Oppenheimer
Triterras downgraded to Perform at Oppenheimer due to volatility, uncertainty
02/01/21 Oppenheimer
Triterras downgraded to Perform from Outperform at Oppenheimer
GPN Global Payments
$132.36 /

-13.315 (-9.14%)

11/03/21 Truist
Global Payments price target lowered to $165 from $240 at Truist
11/03/21 Susquehanna
Global Payments price target lowered to $240 from $250 at Susquehanna
11/03/21 RBC Capital
Global Payments price target lowered to $197 from $221 at RBC Capital
11/03/21 Mizuho
Global Payments price target lowered to $155 from $180 at Mizuho
BP BP
$27.96 /

-1.32 (-4.51%)

10/25/21 TD Securities
BP initiated with a Hold at TD Securities
10/15/21 Berenberg
BP upgraded to Buy from Hold at Berenberg
10/12/21 Morgan Stanley
BP price target raised to 388 GBp from 342 GBp at Morgan Stanley
10/11/21 JPMorgan
BP price target raised to 530 GBp from 510 GBp at JPMorgan
UAA Under Armour
$25.58 /

+3.595 (+16.36%)

11/03/21 Baird
Under Armour price target raised to $32 from $27 at Baird
11/03/21 Deutsche Bank
Under Armour price target raised to $36 from $34 at Deutsche Bank
11/03/21 Telsey Advisory
Under Armour upgraded to Outperform from Market Perform at Telsey Advisory
11/02/21 William Blair
Under Armour upgraded to Outperform at William Blair on valuation, momentum
UA Under Armour
$21.68 /

+2.655 (+13.96%)

11/02/21 Stifel
Stifel raises Under Armour price target to $30 following quarterly results
10/19/21 OTR Global
Under Armour view downgraded to Mixed from Positive at OTR Global
SPG Simon Property
$159.00 /

+9.79 (+6.56%)

11/02/21 Evercore ISI
Simon Property price target raised to $168 at Evercore ISI after 'monster beat'
11/02/21 Compass Point
Simon Property price target raised to $200 from $175 at Compass Point
11/02/21 Mizuho
Simon Property price target raised to $150 from $133 at Mizuho
10/24/21 BofA
Simon Property price target raised to $165 from $150 at BofA
EL Estee Lauder
$338.62 /

+13.305 (+4.09%)

11/03/21 Jefferies
Estee Lauder price target raised to $400 from $384 at Jefferies
11/03/21 Wells Fargo
Estee Lauder price target raised to $375 from $360 at Wells Fargo
10/22/21 Deutsche Bank
Estee Lauder price target lowered to $342 from $347 at Deutsche Bank
10/05/21
Fly Intel: Top five analyst initiations
CLX Clorox
$165.36 /

+1.84 (+1.13%)

11/03/21 Barclays
Clorox price target lowered to $131 from $138 at Barclays
11/02/21 DA Davidson
Clorox price target raised to $162 from $145 at DA Davidson
11/02/21 Deutsche Bank
Clorox price target raised to $160 from $156 at Deutsche Bank
MSFT Microsoft
$333.26 /

+3.43 (+1.04%)

11/01/21 Deutsche Bank
Microsoft initiated with a Buy at Deutsche Bank
10/27/21 Wedbush
Microsoft delivers another 'World-Series' cloud performance, says Wedbush
10/27/21 Credit Suisse
Microsoft price target raised to $340 from $320 at Credit Suisse
10/27/21 Morgan Stanley
Microsoft price target raised to $364 from $331 at Morgan Stanley
YY Joyy
$48.42 /

-3.265 (-6.32%)

XOM Exxon Mobil
$64.82 /

-0.8 (-1.22%)

UAA Under Armour
$25.58 /

+3.595 (+16.36%)

TSLA Tesla
$1,171.99 /

-37.38 (-3.09%)

TEVA Teva
$10.12 /

+0.89 (+9.64%)

SPG Simon Property
$159.00 /

+9.79 (+6.56%)

ROG Rogers Corporation
$270.56 /

+63.56 (+30.71%)

PFE Pfizer
$45.48 /

+1.85 (+4.24%)

NTDOY Nintendo
$53.57 /

-1.97 (-3.55%)

NFLX Netflix
$677.50 /

-3.64 (-0.53%)

MSFT Microsoft
$333.26 /

+3.43 (+1.04%)

JNJ Johnson & Johnson
$165.60 /

+2.58 (+1.58%)

HTZZ Hertz
$35.06 /

+0.91 (+2.66%)

GPN Global Payments
$132.36 /

-13.315 (-9.14%)

FB Facebook; also tag MVRS
$328.17 /

-1.83 (-0.55%)

F Ford
$18.02 /

+0.07 (+0.39%)

EXPE Expedia
$159.86 /

-7.29 (-4.36%)

ENDP Endo
$5.09 /

+0.46 (+9.94%)

EL Estee Lauder
$338.62 /

+13.305 (+4.09%)

DD DuPont
$77.52 /

+6.275 (+8.81%)

CLX Clorox
$165.36 /

+1.84 (+1.13%)

CHGG Chegg
$32.12 /

-30.68 (-48.85%)

CAR Avis Budget
$358.30 /

+186.74 (+108.85%)

BP BP
$27.96 /

-1.32 (-4.51%)

ANET Arista Networks
$491.41 /

+82.83 (+20.27%)

ABBV AbbVie
$116.53 /

+1.63 (+1.42%)

AAPL Apple
$150.03 /

+1.06 (+0.71%)

  • 18
    Feb
  • 19
    Nov
YY Joyy
$48.42 /

-3.265 (-6.32%)

XOM Exxon Mobil
$64.82 /

-0.8 (-1.22%)

UAA Under Armour
$25.58 /

+3.595 (+16.36%)

TSLA Tesla
$1,171.99 /

-37.38 (-3.09%)

TEVA Teva
$10.12 /

+0.89 (+9.64%)

SWBK Switchback II
$8.19 /

-1.81 (-18.10%)

PFE Pfizer
$45.48 /

+1.85 (+4.24%)

NTDOY Nintendo
$53.57 /

-1.97 (-3.55%)

NFLX Netflix
$677.50 /

-3.64 (-0.53%)

MSFT Microsoft
$333.26 /

+3.43 (+1.04%)

JNJ Johnson & Johnson
$165.60 /

+2.58 (+1.58%)

HTZZ Hertz
$35.06 /

+0.91 (+2.66%)

FB Facebook; also tag MVRS
$328.17 /

-1.83 (-0.55%)

F Ford
$18.02 /

+0.07 (+0.39%)

EXPE Expedia
$159.86 /

-7.29 (-4.36%)

ENDP Endo
$5.09 /

+0.46 (+9.94%)

DD DuPont
$77.52 /

+6.275 (+8.81%)

CLX Clorox
$165.36 /

+1.84 (+1.13%)

BP BP
$27.96 /

-1.32 (-4.51%)

ABBV AbbVie
$116.53 /

+1.63 (+1.42%)

AAPL Apple
$150.03 /

+1.06 (+0.71%)

YY Joyy
$48.42 /

-3.265 (-6.32%)

XOM Exxon Mobil
$64.82 /

-0.8 (-1.22%)

UAA Under Armour
$25.58 /

+3.595 (+16.36%)

TSLA Tesla
$1,171.99 /

-37.38 (-3.09%)

SWBK Switchback II
$8.19 /

-1.81 (-18.10%)

SPG Simon Property
$159.00 /

+9.79 (+6.56%)

ROG Rogers Corporation
$270.56 /

+63.56 (+30.71%)

PFE Pfizer
$45.48 /

+1.85 (+4.24%)

NTDOY Nintendo
$53.57 /

-1.97 (-3.55%)

NFLX Netflix
$677.50 /

-3.64 (-0.53%)

JNJ Johnson & Johnson
$165.60 /

+2.58 (+1.58%)

HTZZ Hertz
$35.06 /

+0.91 (+2.66%)

GPN Global Payments
$132.36 /

-13.315 (-9.14%)

FB Facebook; also tag MVRS
$328.17 /

-1.83 (-0.55%)

F Ford
$18.02 /

+0.07 (+0.39%)

EXPE Expedia
$159.86 /

-7.29 (-4.36%)

ENDP Endo
$5.09 /

+0.46 (+9.94%)

EL Estee Lauder
$338.62 /

+13.305 (+4.09%)

DD DuPont
$77.52 /

+6.275 (+8.81%)

CLX Clorox
$165.36 /

+1.84 (+1.13%)

CHGG Chegg
$32.12 /

-30.68 (-48.85%)

BP BP
$27.96 /

-1.32 (-4.51%)

YY Joyy
$48.42 /

-3.265 (-6.32%)

XOM Exxon Mobil
$64.82 /

-0.8 (-1.22%)

UAA Under Armour
$25.58 /

+3.595 (+16.36%)

TSLA Tesla
$1,171.99 /

-37.38 (-3.09%)

TRIT Triterras
$5.43 /

-2.075 (-27.67%)

TEVA Teva
$10.12 /

+0.89 (+9.64%)

SPG Simon Property
$159.00 /

+9.79 (+6.56%)

PFE Pfizer
$45.48 /

+1.85 (+4.24%)

NFLX Netflix
$677.50 /

-3.64 (-0.53%)

MSFT Microsoft
$333.26 /

+3.43 (+1.04%)

JNJ Johnson & Johnson
$165.60 /

+2.58 (+1.58%)

HTZZ Hertz
$35.06 /

+0.91 (+2.66%)

GPN Global Payments
$132.36 /

-13.315 (-9.14%)

FB Facebook; also tag MVRS
$328.17 /

-1.83 (-0.55%)

F Ford
$18.02 /

+0.07 (+0.39%)

EXPE Expedia
$159.86 /

-7.29 (-4.36%)

ENDP Endo
$5.09 /

+0.46 (+9.94%)

EL Estee Lauder
$338.62 /

+13.305 (+4.09%)

DD DuPont
$77.52 /

+6.275 (+8.81%)

CLX Clorox
$165.36 /

+1.84 (+1.13%)

CHGG Chegg
$32.12 /

-30.68 (-48.85%)

CAR Avis Budget
$358.30 /

+186.74 (+108.85%)

BP BP
$27.96 /

-1.32 (-4.51%)

ANET Arista Networks
$491.41 /

+82.83 (+20.27%)

ABBV AbbVie
$116.53 /

+1.63 (+1.42%)

AAPL Apple
$150.03 /

+1.06 (+0.71%)

AAPL Apple
$150.03 /

+1.06 (+0.71%)

Options
Teva call volume above normal and directionally bullish » 12:25
11/02/21
11/02
12:25
11/02/21
12:25
TEVA

Teva

$10.07 /

+0.84 (+9.10%)

Bullish option flow…

Bullish option flow detected in Teva with 53,918 calls trading, 3x expected, and implied vol increasing almost 14 points to 57.60%. 11/5 weekly 10.5 calls and Jan-22 10 calls are the most active options, with total volume in those strikes near 10,300 contracts. The Put/Call Ratio is 0.28. Earnings are expected on February 9th.

ShowHide Related Items >><<
TEVA Teva
$10.07 /

+0.84 (+9.10%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TEVA Teva
$10.07 /

+0.84 (+9.10%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:24
11/02/21
11/02
12:24
11/02/21
12:24
PFE

Pfizer

$45.81 /

+2.175 (+4.99%)

, TSLA

Tesla

$1,167.18 /

-42.19 (-3.49%)

, HTZZ

Hertz

$34.15 /

+3.13 (+10.09%)

, BP

BP

$28.00 /

-1.275 (-4.36%)

, UA

Under Armour

$21.59 /

+2.57 (+13.51%)

, UAA

Under Armour

$25.19 /

+3.21 (+14.60%)

, DD

DuPont

$75.04 /

+3.795 (+5.33%)

, ROG

Rogers Corporation

$269.51 /

+62.51 (+30.20%)

, AAPL

Apple

$150.61 /

+1.64 (+1.10%)

, FB

Facebook; also tag MVRS

$327.44 /

-2.56 (-0.78%)

, BLK

BlackRock

$946.69 /

+10.935 (+1.17%)

, NTDOY

Nintendo

$55.54 /

+0.29 (+0.52%)

, JNJ

Johnson & Johnson

$166.48 /

+3.46 (+2.12%)

, ENDP

Endo

$4.95 /

+0.32 (+6.91%)

, TEVA

Teva

$10.07 /

+0.84 (+9.10%)

, ABBV

AbbVie

$117.30 /

+2.4 (+2.09%)

, CAR

Avis Budget

$313.00 /

+141.44 (+82.44%)

, SWBK

Switchback II

$8.55 /

-1.4501 (-14.50%)

, KNSA

Kiniksa

$15.00 /

+2.27 (+17.83%)

, TRIT

Triterras

$5.35 /

-2.15 (-28.67%)

, GPN

Global Payments

$134.30 /

-11.375 (-7.81%)

, CHGG

Chegg

$34.24 /

-28.56 (-45.48%)

, SPG

Simon Property

$156.07 /

+6.86 (+4.60%)

, EL

Estee Lauder

$337.81 /

+12.495 (+3.84%)

, CLX

Clorox

$168.09 /

+4.57 (+2.79%)

, ANET

Arista Networks

$485.67 /

+77.085 (+18.87%)

, XOM

Exxon Mobil

$64.88 /

-0.74 (-1.13%)

, F

Ford

$17.87 /

-0.08 (-0.45%)

, EXPE

Expedia

$160.10 /

-7.05 (-4.22%)

, YY

Joyy

$47.54 /

-4.14 (-8.01%)

, IT

Gartner

$343.39 /

+15.235 (+4.64%)

Get caught up quickly on…

ShowHide Related Items >><<
YY Joyy
$47.54 /

-4.14 (-8.01%)

XOM Exxon Mobil
$64.88 /

-0.74 (-1.13%)

UAA Under Armour
$25.19 /

+3.21 (+14.60%)

UA Under Armour
$21.59 /

+2.57 (+13.51%)

TSLA Tesla
$1,167.18 /

-42.19 (-3.49%)

TRIT Triterras
$5.35 /

-2.15 (-28.67%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

SWBK Switchback II
$8.55 /

-1.4501 (-14.50%)

SPG Simon Property
$156.07 /

+6.86 (+4.60%)

ROG Rogers Corporation
$269.51 /

+62.51 (+30.20%)

PFE Pfizer
$45.81 /

+2.175 (+4.99%)

NTDOY Nintendo
$55.54 /

+0.29 (+0.52%)

KNSA Kiniksa
$15.00 /

+2.27 (+17.83%)

JNJ Johnson & Johnson
$166.48 /

+3.46 (+2.12%)

IT Gartner
$343.39 /

+15.235 (+4.64%)

HTZZ Hertz
$34.15 /

+3.13 (+10.09%)

GPN Global Payments
$134.30 /

-11.375 (-7.81%)

FB Facebook; also tag MVRS
$327.44 /

-2.56 (-0.78%)

F Ford
$17.87 /

-0.08 (-0.45%)

EXPE Expedia
$160.10 /

-7.05 (-4.22%)

ENDP Endo
$4.95 /

+0.32 (+6.91%)

EL Estee Lauder
$337.81 /

+12.495 (+3.84%)

DD DuPont
$75.04 /

+3.795 (+5.33%)

CLX Clorox
$168.09 /

+4.57 (+2.79%)

CHGG Chegg
$34.24 /

-28.56 (-45.48%)

CAR Avis Budget
$313.00 /

+141.44 (+82.44%)

BP BP
$28.00 /

-1.275 (-4.36%)

BLK BlackRock
$946.69 /

+10.935 (+1.17%)

ANET Arista Networks
$485.67 /

+77.085 (+18.87%)

ABBV AbbVie
$117.30 /

+2.4 (+2.09%)

AAPL Apple
$150.61 /

+1.64 (+1.10%)

PFE Pfizer
$45.81 /

+2.175 (+4.99%)

11/02/21 JPMorgan
Pfizer core sales modestly below expectations, says JPMorgan
10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
TSLA Tesla
$1,167.18 /

-42.19 (-3.49%)

11/02/21 Bernstein
Bernstein sees several structural forces helping Tesla gross margins next year
10/29/21 Canaccord
STMicroelectronics price target raised to $60 from $51 at Canaccord
10/27/21 Piper Sandler
Tesla price target raised to $1,300 from $1,200 at Piper Sandler
10/27/21 Wedbush
Other bulk deals to follow and further benefit Tesla, says Wedbush
HTZZ Hertz
$34.15 /

+3.13 (+10.09%)

10/27/21 William Blair
Deal with Hertz could 'meaningfully' boost Carvana sales, says William Blair
10/27/21 Goldman Sachs
Goldman ups Tesla target to $1,125 after 'important' Hertz order
BP BP
$28.00 /

-1.275 (-4.36%)

10/25/21 TD Securities
BP initiated with a Hold at TD Securities
10/15/21 Berenberg
BP upgraded to Buy from Hold at Berenberg
10/12/21 Morgan Stanley
BP price target raised to 388 GBp from 342 GBp at Morgan Stanley
10/11/21 JPMorgan
BP price target raised to 530 GBp from 510 GBp at JPMorgan
UA Under Armour
$21.59 /

+2.57 (+13.51%)

10/19/21 OTR Global
Under Armour view downgraded to Mixed from Positive at OTR Global
10/04/21 Wedbush
Under Armour initiated with an Outperform at Wedbush
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Cowen
Under Armour price target raised to $33 from $31 at Cowen
UAA Under Armour
$25.19 /

+3.21 (+14.60%)

10/08/21 Cowen
Under Armour price target lowered to $29 from $33 at Cowen
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
DD DuPont
$75.04 /

+3.795 (+5.33%)

10/12/21 Mizuho
DuPont initiated with a Buy at Mizuho
10/04/21
Fly Intel: Top five analyst upgrades
10/04/21 JPMorgan
JPMorgan's Tusa downgrades 3M on lack of progress, prefers DuPont
10/04/21 JPMorgan
DuPont upgraded with share weakness 'overdriven' at JPMorgan
ROG Rogers Corporation
$269.51 /

+62.51 (+30.20%)

07/30/21 Canaccord
Rogers Corporation price target lowered to $233 from $260 at Canaccord
06/09/21 Wolfe Research
Rogers Corporation initiated with an Outperform at Wolfe Research
05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Canaccord
Canaccord starts Rogers with Buy on electrification benefits
AAPL Apple
$150.61 /

+1.64 (+1.10%)

11/02/21 Morgan Stanley
Apple 10-K highlights strong advertising growth, says Morgan Stanley
11/01/21 Canaccord
Apple results show underlying demand remains strong, says Canaccord
10/29/21 Evercore ISI
Apple still positioned for mid-teens EPS growth in FY22, says Evercore ISI
10/29/21 Citi
Apple sales miss not 'thesis changer,' says Citi
FB Facebook; also tag MVRS
$327.44 /

-2.56 (-0.78%)

11/01/21 Citi
Citi upgrades Snap to Neutral, cuts price target to $53
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
10/27/21 Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
BLK BlackRock
$946.69 /

+10.935 (+1.17%)

10/14/21 BMO Capital
BlackRock price target lowered to $794 from $797 at BMO Capital
10/14/21 Deutsche Bank
BlackRock price target lowered to $1,008 from $1,039 at Deutsche Bank
10/14/21 Citi
BlackRock price target raised to $1,035 from $1,030 at Citi
10/12/21 BofA
Humana, Teradata added to US 1 List, BlackRock removed at BofA
NTDOY Nintendo
$55.54 /

+0.29 (+0.52%)

10/28/21 Wedbush
Nintendo upgraded to Outperform from Neutral at Wedbush
10/01/21 DZ Bank
Nintendo downgraded to Hold from Buy at DZ Bank
08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
JNJ Johnson & Johnson
$166.48 /

+3.46 (+2.12%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
ENDP Endo
$4.95 /

+0.32 (+6.91%)

08/31/21 Piper Sandler
Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
08/31/21 Piper Sandler
Endo downgraded to Neutral from Overweight at Piper Sandler
08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
TEVA Teva
$10.07 /

+0.84 (+9.10%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
ABBV AbbVie
$117.30 /

+2.4 (+2.09%)

11/01/21 Morgan Stanley
AbbVie price target raised to $124 from $116 at Morgan Stanley
10/29/21 Piper Sandler
AbbVie price target raised to $129 from $124 at Piper Sandler
10/19/21 Morgan Stanley
Regenxbio assumed with an Overweight at Morgan Stanley
10/05/21 Piper Sandler
Biohaven Pharmaceutical price target raised to $156 from $140 at Piper Sandler
CAR Avis Budget
$313.00 /

+141.44 (+82.44%)

11/02/21 Morgan Stanley
Avis Budget price target raised to $140 from $110 at Morgan Stanley
10/29/21 Deutsche Bank
Avis Budget price target raised to $119 from $92 at Deutsche Bank
10/28/21
Fly Intel: Top five analyst downgrades
10/28/21 BofA
Avis Budget downgraded to Neutral from Buy at BofA
SWBK Switchback II
$8.55 /

-1.4501 (-14.50%)

09/23/21 DA Davidson
Switchback II initiated with a Buy at DA Davidson
08/30/21 Capital One
Switchback II initiated with an Overweight at Capital One
KNSA Kiniksa
$15.00 /

+2.27 (+17.83%)

11/02/21 JPMorgan
Kiniksa added to Analyst Focus List at JPMorgan
08/04/21 Wedbush
Kiniksa price target lowered to $24 from $32 at Wedbush
03/18/21 Evercore ISI
Kiniksa sNDA looks to be approved by FDA, says Evercore ISI
11/24/20 Evercore ISI
Kiniksa initiated with an Outperform at Evercore ISI
TRIT Triterras
$5.35 /

-2.15 (-28.67%)

11/02/21 B. Riley
Triterras downgraded to Neutral from Buy at B. Riley
05/18/21 B. Riley
Triterras price target lowered to $9 from $12 at B. Riley
02/01/21 Oppenheimer
Triterras downgraded to Perform at Oppenheimer due to volatility, uncertainty
02/01/21 Oppenheimer
Triterras downgraded to Perform from Outperform at Oppenheimer
GPN Global Payments
$134.30 /

-11.375 (-7.81%)

10/21/21 Barclays
Barclays 'mildly cautious' into Global Payments results
09/10/21 Morgan Stanley
Global Payments price target lowered to $185 from $219 at Morgan Stanley
09/09/21 BMO Capital
Global Payments price target raised to $217 from $206 at BMO Capital
08/17/21 JPMorgan
Global Payments price target raised to $224 from $220 at JPMorgan
CHGG Chegg
$34.24 /

-28.56 (-45.48%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 BMO Capital
Chegg price target lowered to $49 from $74 at BMO Capital
11/02/21 Raymond James
Chegg downgraded to Market Perform from Outperform at Raymond James
11/02/21 Barrington
Chegg earnings selloff a buying opportunity, says Barrington
SPG Simon Property
$156.07 /

+6.86 (+4.60%)

11/02/21 Evercore ISI
Simon Property price target raised to $168 at Evercore ISI after 'monster beat'
11/02/21 Compass Point
Simon Property price target raised to $200 from $175 at Compass Point
11/02/21 Mizuho
Simon Property price target raised to $150 from $133 at Mizuho
10/24/21 BofA
Simon Property price target raised to $165 from $150 at BofA
EL Estee Lauder
$337.81 /

+12.495 (+3.84%)

10/22/21 Deutsche Bank
Estee Lauder price target lowered to $342 from $347 at Deutsche Bank
10/05/21
Fly Intel: Top five analyst initiations
10/05/21 BofA
Estee Lauder reinitiated with a Buy at BofA
10/05/21 BofA
Estee Lauder reinitiated with a Buy at BofA
CLX Clorox
$168.09 /

+4.57 (+2.79%)

11/02/21 DA Davidson
Clorox price target raised to $162 from $145 at DA Davidson
11/02/21 Deutsche Bank
Clorox price target raised to $160 from $156 at Deutsche Bank
11/02/21 JPMorgan
Clorox downgraded to Underweight from Neutral at JPMorgan
ANET Arista Networks
$485.67 /

+77.085 (+18.87%)

11/02/21 BofA
Arista Networks price target raised to $480 from $400 at BofA
11/02/21 Cowen
Arista Networks price target raised to $535 from $433 at Cowen
11/02/21 Evercore ISI
Arista Networks price target raised to $520 from $480 at Evercore ISI
11/02/21 Morgan Stanley
Arista Networks price target raised to $460 from $420 at Morgan Stanley
XOM Exxon Mobil
$64.88 /

-0.74 (-1.13%)

11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
F Ford
$17.87 /

-0.08 (-0.45%)

11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
11/02/21 Nomura
Ford downgraded to Reduce from Neutral at Nomura
10/29/21 Tigress Financial
Snap-On price target raised to $295 from $289 at Tigress Financial
10/28/21 Benchmark
Ford price target raised to $20 from $18 at Benchmark
EXPE Expedia
$160.10 /

-7.05 (-4.22%)

11/02/21 Atlantic Equities
Expedia downgraded to Neutral on valuation at Atlantic Equities
11/02/21 Atlantic Equities
Expedia downgraded to Neutral from Overweight at Atlantic Equities
09/13/21 Goldman Sachs
Expedia initiated with a Buy at Goldman Sachs
YY Joyy
$47.54 /

-4.14 (-8.01%)

11/02/21 Morgan Stanley
Joyy named as Research Tactical Idea at Morgan Stanley
11/01/21 Goldman Sachs
Joyy downgraded to Sell from Neutral at Goldman Sachs
08/19/21 Benchmark
Joyy price target lowered to $97 from $165 at Benchmark
07/16/21 Morgan Stanley
Joyy price target lowered to $80 from $141 at Morgan Stanley
IT Gartner
$343.39 /

+15.235 (+4.64%)

08/04/21 BMO Capital
Gartner price target raised to $280 from $234 at BMO Capital
06/29/21 Morgan Stanley
Gartner price target raised to $266 from $250 at Morgan Stanley
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
02/10/21 Wells Fargo
Gartner price target raised to $187 from $145 at Wells Fargo
YY Joyy
$47.54 /

-4.14 (-8.01%)

XOM Exxon Mobil
$64.88 /

-0.74 (-1.13%)

UA Under Armour
$21.59 /

+2.57 (+13.51%)

TSLA Tesla
$1,167.18 /

-42.19 (-3.49%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

SPG Simon Property
$156.07 /

+6.86 (+4.60%)

ROG Rogers Corporation
$269.51 /

+62.51 (+30.20%)

PFE Pfizer
$45.81 /

+2.175 (+4.99%)

NTDOY Nintendo
$55.54 /

+0.29 (+0.52%)

KNSA Kiniksa
$15.00 /

+2.27 (+17.83%)

JNJ Johnson & Johnson
$166.48 /

+3.46 (+2.12%)

IT Gartner
$343.39 /

+15.235 (+4.64%)

HTZZ Hertz
$34.15 /

+3.13 (+10.09%)

GPN Global Payments
$134.30 /

-11.375 (-7.81%)

FB Facebook; also tag MVRS
$327.44 /

-2.56 (-0.78%)

F Ford
$17.87 /

-0.08 (-0.45%)

EXPE Expedia
$160.10 /

-7.05 (-4.22%)

ENDP Endo
$4.95 /

+0.32 (+6.91%)

EL Estee Lauder
$337.81 /

+12.495 (+3.84%)

DD DuPont
$75.04 /

+3.795 (+5.33%)

CLX Clorox
$168.09 /

+4.57 (+2.79%)

CHGG Chegg
$34.24 /

-28.56 (-45.48%)

CAR Avis Budget
$313.00 /

+141.44 (+82.44%)

BP BP
$28.00 /

-1.275 (-4.36%)

BLK BlackRock
$946.69 /

+10.935 (+1.17%)

ANET Arista Networks
$485.67 /

+77.085 (+18.87%)

ABBV AbbVie
$117.30 /

+2.4 (+2.09%)

AAPL Apple
$150.61 /

+1.64 (+1.10%)

  • 18
    Feb
  • 19
    Nov
YY Joyy
$47.54 /

-4.14 (-8.01%)

XOM Exxon Mobil
$64.88 /

-0.74 (-1.13%)

UA Under Armour
$21.59 /

+2.57 (+13.51%)

TSLA Tesla
$1,167.18 /

-42.19 (-3.49%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

SWBK Switchback II
$8.55 /

-1.4501 (-14.50%)

PFE Pfizer
$45.81 /

+2.175 (+4.99%)

NTDOY Nintendo
$55.54 /

+0.29 (+0.52%)

JNJ Johnson & Johnson
$166.48 /

+3.46 (+2.12%)

HTZZ Hertz
$34.15 /

+3.13 (+10.09%)

FB Facebook; also tag MVRS
$327.44 /

-2.56 (-0.78%)

F Ford
$17.87 /

-0.08 (-0.45%)

EXPE Expedia
$160.10 /

-7.05 (-4.22%)

ENDP Endo
$4.95 /

+0.32 (+6.91%)

DD DuPont
$75.04 /

+3.795 (+5.33%)

CLX Clorox
$168.09 /

+4.57 (+2.79%)

BP BP
$28.00 /

-1.275 (-4.36%)

BLK BlackRock
$946.69 /

+10.935 (+1.17%)

ABBV AbbVie
$117.30 /

+2.4 (+2.09%)

AAPL Apple
$150.61 /

+1.64 (+1.10%)

YY Joyy
$47.54 /

-4.14 (-8.01%)

XOM Exxon Mobil
$64.88 /

-0.74 (-1.13%)

UA Under Armour
$21.59 /

+2.57 (+13.51%)

TSLA Tesla
$1,167.18 /

-42.19 (-3.49%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

SWBK Switchback II
$8.55 /

-1.4501 (-14.50%)

SPG Simon Property
$156.07 /

+6.86 (+4.60%)

ROG Rogers Corporation
$269.51 /

+62.51 (+30.20%)

PFE Pfizer
$45.81 /

+2.175 (+4.99%)

NTDOY Nintendo
$55.54 /

+0.29 (+0.52%)

JNJ Johnson & Johnson
$166.48 /

+3.46 (+2.12%)

IT Gartner
$343.39 /

+15.235 (+4.64%)

HTZZ Hertz
$34.15 /

+3.13 (+10.09%)

GPN Global Payments
$134.30 /

-11.375 (-7.81%)

FB Facebook; also tag MVRS
$327.44 /

-2.56 (-0.78%)

F Ford
$17.87 /

-0.08 (-0.45%)

EXPE Expedia
$160.10 /

-7.05 (-4.22%)

ENDP Endo
$4.95 /

+0.32 (+6.91%)

EL Estee Lauder
$337.81 /

+12.495 (+3.84%)

DD DuPont
$75.04 /

+3.795 (+5.33%)

CLX Clorox
$168.09 /

+4.57 (+2.79%)

CHGG Chegg
$34.24 /

-28.56 (-45.48%)

CAR Avis Budget
$313.00 /

+141.44 (+82.44%)

BP BP
$28.00 /

-1.275 (-4.36%)

BLK BlackRock
$946.69 /

+10.935 (+1.17%)

ANET Arista Networks
$485.67 /

+77.085 (+18.87%)

ABBV AbbVie
$117.30 /

+2.4 (+2.09%)

AAPL Apple
$150.61 /

+1.64 (+1.10%)

YY Joyy
$47.54 /

-4.14 (-8.01%)

XOM Exxon Mobil
$64.88 /

-0.74 (-1.13%)

UAA Under Armour
$25.19 /

+3.21 (+14.60%)

TSLA Tesla
$1,167.18 /

-42.19 (-3.49%)

TRIT Triterras
$5.35 /

-2.15 (-28.67%)

TEVA Teva
$10.07 /

+0.84 (+9.10%)

SPG Simon Property
$156.07 /

+6.86 (+4.60%)

PFE Pfizer
$45.81 /

+2.175 (+4.99%)

JNJ Johnson & Johnson
$166.48 /

+3.46 (+2.12%)

IT Gartner
$343.39 /

+15.235 (+4.64%)

HTZZ Hertz
$34.15 /

+3.13 (+10.09%)

GPN Global Payments
$134.30 /

-11.375 (-7.81%)

FB Facebook; also tag MVRS
$327.44 /

-2.56 (-0.78%)

F Ford
$17.87 /

-0.08 (-0.45%)

EXPE Expedia
$160.10 /

-7.05 (-4.22%)

ENDP Endo
$4.95 /

+0.32 (+6.91%)

EL Estee Lauder
$337.81 /

+12.495 (+3.84%)

DD DuPont
$75.04 /

+3.795 (+5.33%)

CLX Clorox
$168.09 /

+4.57 (+2.79%)

CHGG Chegg
$34.24 /

-28.56 (-45.48%)

CAR Avis Budget
$313.00 /

+141.44 (+82.44%)

BP BP
$28.00 /

-1.275 (-4.36%)

ANET Arista Networks
$485.67 /

+77.085 (+18.87%)

ABBV AbbVie
$117.30 /

+2.4 (+2.09%)

AAPL Apple
$150.61 /

+1.64 (+1.10%)

AAPL Apple
$150.61 /

+1.64 (+1.10%)

On The Fly
Fly Intel: Pre-market Movers » 08:56
11/02/21
11/02
08:56
11/02/21
08:56
TEVA

Teva

$9.23 /

+0.475 (+5.43%)

, PFE

Pfizer

$43.63 /

-0.12 (-0.27%)

, UAA

Under Armour

$21.98 /

+0.01 (+0.05%)

, UA

Under Armour

$19.02 /

+0.14 (+0.74%)

, CTLT

Catalent

$138.96 /

+1.1 (+0.80%)

, ANET

Arista Networks

$408.73 /

-1.42 (-0.35%)

, EL

Estee Lauder

$325.30 /

+1.09 (+0.34%)

, GPN

Global Payments

$145.68 /

+2.695 (+1.88%)

, BLMN

Bloomin' Brands

$22.58 /

+0.96 (+4.44%)

, LCII

LCI Industries

$142.14 /

+3.35 (+2.41%)

, CHGG

Chegg

$62.74 /

+3.275 (+5.51%)

, TSLA

Tesla

$1,209.42 /

+95.24 (+8.55%)

, ROG

Rogers Corporation

$208.23 /

+8.73 (+4.38%)

, DD

DuPont

$71.25 /

+1.665 (+2.39%)

Check out this morning's…

ShowHide Related Items >><<
UAA Under Armour
$21.98 /

+0.01 (+0.05%)

TSLA Tesla
$1,209.42 /

+95.24 (+8.55%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

ROG Rogers Corporation
$208.23 /

+8.73 (+4.38%)

PFE Pfizer
$43.63 /

-0.12 (-0.27%)

LCII LCI Industries
$142.14 /

+3.35 (+2.41%)

GPN Global Payments
$145.68 /

+2.695 (+1.88%)

EL Estee Lauder
$325.30 /

+1.09 (+0.34%)

DD DuPont
$71.25 /

+1.665 (+2.39%)

CTLT Catalent
$138.96 /

+1.1 (+0.80%)

CHGG Chegg
$62.74 /

+3.275 (+5.51%)

BLMN Bloomin' Brands
$22.58 /

+0.96 (+4.44%)

ANET Arista Networks
$408.73 /

-1.42 (-0.35%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
PFE Pfizer
$43.63 /

-0.12 (-0.27%)

11/02/21 JPMorgan
Pfizer core sales modestly below expectations, says JPMorgan
10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
UAA Under Armour
$21.98 /

+0.01 (+0.05%)

10/19/21 OTR Global
Under Armour view downgraded to Mixed from Positive at OTR Global
10/08/21 Cowen
Under Armour price target lowered to $29 from $33 at Cowen
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
UA Under Armour
$19.02 /

+0.14 (+0.74%)

10/04/21 Wedbush
Under Armour initiated with an Outperform at Wedbush
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Cowen
Under Armour price target raised to $33 from $31 at Cowen
CTLT Catalent
$138.96 /

+1.1 (+0.80%)

09/08/21 Deutsche Bank
Catalent price target raised to $162 from $123 at Deutsche Bank
08/31/21 UBS
Catalent price target raised to $145 from $138 at UBS
08/31/21 KeyBanc
Catalent price target raised to $155 from $142 at KeyBanc
08/31/21 RBC Capital
Catalent price target raised to $145 from $137 at RBC Capital
ANET Arista Networks
$408.73 /

-1.42 (-0.35%)

11/02/21 Cowen
Arista Networks price target raised to $535 from $433 at Cowen
11/02/21 Evercore ISI
Arista Networks price target raised to $520 from $480 at Evercore ISI
11/02/21 Morgan Stanley
Arista Networks price target raised to $460 from $420 at Morgan Stanley
11/02/21 Credit Suisse
Arista Networks price target raised to $509 from $410 at Credit Suisse
EL Estee Lauder
$325.30 /

+1.09 (+0.34%)

10/22/21 Deutsche Bank
Estee Lauder price target lowered to $342 from $347 at Deutsche Bank
10/05/21
Fly Intel: Top five analyst initiations
10/05/21 BofA
Estee Lauder reinitiated with a Buy at BofA
10/05/21 BofA
Estee Lauder reinitiated with a Buy at BofA
GPN Global Payments
$145.68 /

+2.695 (+1.88%)

10/21/21 Barclays
Barclays 'mildly cautious' into Global Payments results
09/10/21 Morgan Stanley
Global Payments price target lowered to $185 from $219 at Morgan Stanley
09/09/21 BMO Capital
Global Payments price target raised to $217 from $206 at BMO Capital
08/17/21 JPMorgan
Global Payments price target raised to $224 from $220 at JPMorgan
BLMN Bloomin' Brands
$22.58 /

+0.96 (+4.44%)

08/03/21 Goldman Sachs
Bloomin' Brands upgraded to Neutral from Sell at Goldman Sachs
08/03/21 Credit Suisse
Bloomin' Brands upgraded to Outperform from Neutral at Credit Suisse
08/02/21
Fly Intel: Top five analyst upgrades
08/02/21 Deutsche Bank
Bloomin' Brands upgraded to Buy from Hold at Deutsche Bank
LCII LCI Industries
$142.14 /

+3.35 (+2.41%)

07/15/21 Truist
LCI Industries initiated with a Buy at Truist
07/15/21 Truist
LCI Industries initiated with a Buy at Truist
06/17/21 Northcoast
Northcoast downgrades three RV makers to Neutral following industry checks
05/05/21 Baird
LCI Industries price target raised to $165 from $160 at Baird
CHGG Chegg
$62.74 /

+3.275 (+5.51%)

11/02/21 Barrington
Chegg earnings selloff a buying opportunity, says Barrington
11/02/21 Craig-Hallum
Craig-Hallum downgrades Chegg to Hold, cuts target to $50
11/02/21 Citi
Chegg downgraded to Neutral from Buy at Citi
11/02/21 Northland
Northland cuts Chegg to Market Perform on education industry downturn
TSLA Tesla
$1,209.42 /

+95.24 (+8.55%)

11/02/21 Bernstein
Bernstein sees several structural forces helping Tesla gross margins next year
10/29/21 Canaccord
STMicroelectronics price target raised to $60 from $51 at Canaccord
10/27/21 Piper Sandler
Tesla price target raised to $1,300 from $1,200 at Piper Sandler
10/27/21 Wedbush
Other bulk deals to follow and further benefit Tesla, says Wedbush
ROG Rogers Corporation
$208.23 /

+8.73 (+4.38%)

07/30/21 Canaccord
Rogers Corporation price target lowered to $233 from $260 at Canaccord
06/09/21 Wolfe Research
Rogers Corporation initiated with an Outperform at Wolfe Research
05/26/21
Fly Intel: Top five analyst initiations
05/26/21 Canaccord
Canaccord starts Rogers with Buy on electrification benefits
DD DuPont
$71.25 /

+1.665 (+2.39%)

10/12/21 Mizuho
DuPont initiated with a Buy at Mizuho
10/04/21
Fly Intel: Top five analyst upgrades
10/04/21 JPMorgan
JPMorgan's Tusa downgrades 3M on lack of progress, prefers DuPont
10/04/21 JPMorgan
DuPont upgraded with share weakness 'overdriven' at JPMorgan
UAA Under Armour
$21.98 /

+0.01 (+0.05%)

TSLA Tesla
$1,209.42 /

+95.24 (+8.55%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

ROG Rogers Corporation
$208.23 /

+8.73 (+4.38%)

PFE Pfizer
$43.63 /

-0.12 (-0.27%)

LCII LCI Industries
$142.14 /

+3.35 (+2.41%)

GPN Global Payments
$145.68 /

+2.695 (+1.88%)

EL Estee Lauder
$325.30 /

+1.09 (+0.34%)

DD DuPont
$71.25 /

+1.665 (+2.39%)

CTLT Catalent
$138.96 /

+1.1 (+0.80%)

CHGG Chegg
$62.74 /

+3.275 (+5.51%)

BLMN Bloomin' Brands
$22.58 /

+0.96 (+4.44%)

ANET Arista Networks
$408.73 /

-1.42 (-0.35%)

  • 18
    Feb
  • 23
    Nov
UAA Under Armour
$21.98 /

+0.01 (+0.05%)

TSLA Tesla
$1,209.42 /

+95.24 (+8.55%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

PFE Pfizer
$43.63 /

-0.12 (-0.27%)

DD DuPont
$71.25 /

+1.665 (+2.39%)

CTLT Catalent
$138.96 /

+1.1 (+0.80%)

UAA Under Armour
$21.98 /

+0.01 (+0.05%)

TSLA Tesla
$1,209.42 /

+95.24 (+8.55%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

ROG Rogers Corporation
$208.23 /

+8.73 (+4.38%)

PFE Pfizer
$43.63 /

-0.12 (-0.27%)

GPN Global Payments
$145.68 /

+2.695 (+1.88%)

EL Estee Lauder
$325.30 /

+1.09 (+0.34%)

DD DuPont
$71.25 /

+1.665 (+2.39%)

CTLT Catalent
$138.96 /

+1.1 (+0.80%)

CHGG Chegg
$62.74 /

+3.275 (+5.51%)

ANET Arista Networks
$408.73 /

-1.42 (-0.35%)

UAA Under Armour
$21.98 /

+0.01 (+0.05%)

TSLA Tesla
$1,209.42 /

+95.24 (+8.55%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

PFE Pfizer
$43.63 /

-0.12 (-0.27%)

GPN Global Payments
$145.68 /

+2.695 (+1.88%)

EL Estee Lauder
$325.30 /

+1.09 (+0.34%)

DD DuPont
$71.25 /

+1.665 (+2.39%)

CHGG Chegg
$62.74 /

+3.275 (+5.51%)

ANET Arista Networks
$408.73 /

-1.42 (-0.35%)

Periodicals
J&J, Teva, others beat win $50B opioid case in California, Bloomberg reports » 06:30
11/02/21
11/02
06:30
11/02/21
06:30
JNJ

Johnson & Johnson

$163.01 /

+0.19 (+0.12%)

, TEVA

Teva

$9.23 /

+0.475 (+5.43%)

, ENDP

Endo

$4.63 /

+0.36 (+8.43%)

, ABBV

AbbVie

$114.84 /

+0.13 (+0.11%)

Johnson & Johnson…

Johnson & Johnson (JNJ), Teva Pharmaceuticals (TEVA), Endo International (ENDP), and Abbvie's (ABBV) Allergan won the first case for pharmaceutical companies in the four-year litigation over the drugs, defeating a lawsuit made by local governments in California that claimed the companies created a public health crisis related to opioid painkillers due to misleading marketing, Jef Feeley of Bloomberg reports. On Monday, Superior Court Judge Peter Wilson in Santa Ana rejected claims these pharmaceutical companies tricked patients and doctors about the addictiveness of opioid painkillers. Officials in Santa Ana and several other counties sought as much as $50B from these pharmaceutical companies to improve policing and treatment budgets. "The court finds plaintiffs failed to prove an actionable public nuisance for which the defendants are legally liable," Wilson concluded, according to Bloomberg. The lawyers for the local governments already said they will be asking the California appeals court to review this ruling. Reference Link

ShowHide Related Items >><<
TEVA Teva
$9.23 /

+0.475 (+5.43%)

JNJ Johnson & Johnson
$163.01 /

+0.19 (+0.12%)

ENDP Endo
$4.63 /

+0.36 (+8.43%)

ABBV AbbVie
$114.84 /

+0.13 (+0.11%)

JNJ Johnson & Johnson
$163.01 /

+0.19 (+0.12%)

10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
10/20/21 Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
TEVA Teva
$9.23 /

+0.475 (+5.43%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
ENDP Endo
$4.63 /

+0.36 (+8.43%)

08/31/21 Piper Sandler
Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
08/31/21 Piper Sandler
Endo downgraded to Neutral from Overweight at Piper Sandler
08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
ABBV AbbVie
$114.84 /

+0.13 (+0.11%)

11/01/21 Morgan Stanley
AbbVie price target raised to $124 from $116 at Morgan Stanley
10/29/21 Piper Sandler
AbbVie price target raised to $129 from $124 at Piper Sandler
10/19/21 Morgan Stanley
Regenxbio assumed with an Overweight at Morgan Stanley
10/05/21 Piper Sandler
Biohaven Pharmaceutical price target raised to $156 from $140 at Piper Sandler
TEVA Teva
$9.23 /

+0.475 (+5.43%)

JNJ Johnson & Johnson
$163.01 /

+0.19 (+0.12%)

ENDP Endo
$4.63 /

+0.36 (+8.43%)

ABBV AbbVie
$114.84 /

+0.13 (+0.11%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

JNJ Johnson & Johnson
$163.01 /

+0.19 (+0.12%)

ENDP Endo
$4.63 /

+0.36 (+8.43%)

ABBV AbbVie
$114.84 /

+0.13 (+0.11%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

JNJ Johnson & Johnson
$163.01 /

+0.19 (+0.12%)

ENDP Endo
$4.63 /

+0.36 (+8.43%)

ABBV AbbVie
$114.84 /

+0.13 (+0.11%)

TEVA Teva
$9.23 /

+0.475 (+5.43%)

JNJ Johnson & Johnson
$163.01 /

+0.19 (+0.12%)

ENDP Endo
$4.63 /

+0.36 (+8.43%)

ABBV AbbVie
$114.84 /

+0.13 (+0.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.